Ottawa, ON – April 17, 2025 – This morning, following a panel discussion at the annual Canadian Nuclear Association (CNA) 2025 Conference, the Canadian Nuclear Isotope Council (CNIC) and the CNA signed a new Memorandum of Understanding (MoU) which highlights the organizations’ plans for increased collaboration in support of Canada’s nuclear isotope sector.
As part of its Isotopes for Hope campaign, the CNIC has established a vision to double isotope production in Canada by 2030. Collaboration with other leading industry organizations like the CNA and its members is critical to achieving this goal.
Since its establishment in 2018, the CNIC has brought Canadian and international organizations from the nuclear, healthcare, and radiopharmaceutical sectors together to expand access to radiopharmaceuticals and increase the production of isotopes in Canada through events, thought leadership, and advocacy.
Similarly, the CNA has been the national voice of the Canadian nuclear industry since 1960, working with its members to promote the Canadian nuclear industry nationally and internationally, and working with governments on policies affecting the sector.
Both organizations lead government relations, policy development and advocacy work with various levels of government across the country but have not previously established a formal mechanism to align and coordinate their efforts.
The MoU signed this morning by the CNIC’s Chair, James Scongack, and the CNA’s Acting President & CEO, George Christidis, detailed the steps that both organizations will take to collaborate on policy development, advocacy, and event programming regarding nuclear isotopes. This new coordination effort, particularly on policy development and advocacy, will help ensure that both organizations remain aligned when working with federal and provincial government partners to support Canada’s nuclear isotope sector.
“I was pleased to join the CNA’s Acting President & CEO, George Christidis, this morning to sign this historic MoU between our two organizations. As the global isotope market continues to grow, it is more important than ever that our entire sector is united. Today’s announcement will help ensure that the broader nuclear technology sector is aligned in our advocacy and policy development work, increasing the scope and impact of our individual efforts by combining both powerful voices into one,” said James Scongack, Chair of the CNIC. “Through this collaboration, the CNIC will continue to advocate for further investment in and support for the sector to help meet our goal of doubling isotope production in Canada by 2030 to ensure that patients across the country and around the world have access to life-changing medical isotopes.”
“The signing of this MoU demonstrates the CNA’s commitment to collaborate with the CNIC in order to further their mission of maintaining Canada’s position as a global leader in the production of life-saving medical isotopes,” said George Christidis, Acting President & CEO of CNA. “The CNIC’s vision to double isotope production in Canada by 2030 aligns with CNA’s commitment to supporting Canada’s growth as a global leader in nuclear medicine. We are stronger together in our efforts to improve the lives of patients in Canada and beyond.”
This announcement concluded the CNIC’s successful engagements at the CNA2025 conference, including this morning’s panel discussion which showcased Canada’s isotope supply chain and highlighted how we can continue to build our future as an isotope superpower.
To learn more about the Canadian Nuclear Association, visit their website here: https://cna.ca/
About the Canadian Nuclear Isotope Council
The Canadian Nuclear Isotope Council (CNIC) is an independent, not-for-profit advocacy and member services organization. The CNIC supports over 100 members from across science, academia, healthcare, and nuclear-sector organizations dedicated to maintaining Canada’s position as a global leader in the production of life-saving isotopes. The CNIC raises awareness and advocates for long-term policies that support health-care innovation and will save countless lives for decades to come.
To learn more about the CNIC, visit www.CanadianIsotopes.ca and follow us on Facebook, Twitter, and LinkedIn, or please contact:
Melody Greaves
Executive Director and Vice President, Government Relations
Canadian Nuclear Isotope Council
melody.greaves@canadianisotopes.ca